CLINICAL_TRIALS
trial_result
· 2025-09-24
Clinical Trial Update: Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) [Phase 2]
Summary
Imaging-based results from a Phase 2 study evaluating PLN-74809 in participants with idiopathic pulmonary fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pliant Therapeutics, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-24